Lyme Disease Diagnostics Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028
Lyme Disease Diagnostics Market |
The spreading red rash known as erythema migrans that appears about a week after a tick bite is the most typical sign of infection. Lyme disease is diagnosed using a variety of diagnostic procedures, including a serological test, PCR analysis, immunofluorescence analysis, lymphocyte transformation analysis, urine antigen analysis, and others. The rise in incidence and prevalence of Lyme disease, as well as the spike in financing from governmental agencies and major corporations for the development of Lyme disease diagnostic kits, can be attributed to the growth of the global market for Lyme disease diagnostics.
In 2020, North America dominated the global market for Lyme
disease diagnostics, and it is predicted that this trend will persist over the
coming years. The market in the region is driven by the presence of important
market participants, high healthcare spending, and early product availability.
Additionally, the U.S. has a sizable patient population, and the number of
companies offering diagnostic services for Lyme disease is rising. During the
projection period, Europe is anticipated to be the second-largest market for
Lyme disease diagnostics.
Comments
Post a Comment